Subject
Cellular and Molecular Neuroscience,Neurology (clinical)
Reference47 articles.
1. The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®);Morgante;Ther. Adv. Neurol. Disord.,2020
2. Management of oral secretions in neurological disease;McGeachan;Pract. Neurol.,2017
3. Drooling in Parkinson’s disease: prevalence and progression from the Non-motor International Longitudinal Study;Van Wamelen;Dysphagia,2020
4. Drooling in Parkinson’s disease: a review;Srivanitchapoom;Parkinsonism Relat. Disord.,2014
5. D. Santos-García, T. de Deus Fonticoba, C. Cores Bartolomé, M.J. Feal Painceiras, M.C. Íñiguez-Alvarado, S. Jesús, M.T. Buongiorno, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M.A. Ávila Rivera, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. Dotor García-Soto, C. Borrué, B. Solano Vila, M. Álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J.C. Martínez Castrillo, P. Sánchez Alonso, M.G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez Estrada, M. Seijo, J. Rúiz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González Ardura, R. Alonso Redondo, C. Ordás, L.M.L. López Díaz, D. McAfee, P. Martinez-Martin, P. Mir, S.G. Coppadis. Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group, Parkinsons Dis. 6 (2023) 3104425.